Integra LifeSciences Holdings Corp. (IART)
The Company is dedicated to improving the quality of life for patients through the development, manufacturing and marketing of cost-effective surgical implants and medical instruments.
Recs
I like their product line-up and I like the management of the company. I think this is a solid company that's making the right moves in a tough economy.
Recs
IART
Recs
This company has been a consistent performer even through the past years misery. It looks good through $40 to $45 but then re-evaluate. I'm long term on this one and it is one of a few that keep me afloat.
Recs
Just a good, innovative business in the health care industry which will grow and grow.
Recs
To be honest, I'm going on 'gut' with this one. The markets niches they are addressing seem to offer good growth oppty. They have a solid track record which implies good management. Perhaps too acquisition-oriented and they compete against much larger companies. On the other hand, they might make a good acquisition target for one of their strategic partners.
Recs
Solid performer poised for continued stellar growth given its industry standing and demographic trends. Now is a good time to get in.
Recs
Integra is a New Jersey-based $1.28 billion market cap company developing, manufacturing, and selling medical devices, implants, biomaterials, and instruments to the neurosurgery, surgery, and soft tissue repair markets.
As of 10/4/2007, IART has a P/E of 47.12, a P/S of 2.57, and a PEG of 1.23.
Buy and hold long.
Recs
Can you say, "they make brain tissue oxygen sensors?" As long as we have private healthcare in this country they will continue to outperform. The classic, "baby boomers are getting old play," and they make products, not provide services.
Recs
I currently work for a company that Integra is buying out. The purchase of my company was very smart. It is a money maker and will provide them an awesome sales force.
Recs
Integra is a world leader in regenerative medicine and in applying the principles of biotechnology to medical devices, particularly for neurosurgery and extremity reconstruction. It is one of the largest surgical instrument companies in the United States. The company is engaged in development, manufacturing and marketing of cost-effective surgical implants and medical instruments which are primarily used in neurosurgery, extremity reconstruction, orthopedics and general surgery.
The company recently reported a 72% increase in the revenues for the fourth quarter of 2006 and 51% for the whole year on a Y-O-Y basis. This increase in the revenue was a result of new product launches, better selling of existing products and acquisitions. The company is strategically growing the breadth and death of its product offerings and sales organizations by new product launches and acquisitions. In line with this approach the company recently acquired KMI, and expanded its extremity-reconstruction product line to include the hand, wrist and arm. The company also expanded its neurosurgery franchise by acquiring Radionics and the recruiting specialist groups focused on the intensive care unit and spine surgeons.
The company also extended its agreement with Wyeth and Medtronic for ACS, AMPLIFY and MasterGraft and its Jarit Surgical Instruments subsidiary recently signed a three-year contract to supply Jarit(R) surgical and laparoscopic instruments to members of Premier Purchasing Partners, one of the largest healthcare alliances in the United States. With all these long- term contracts under its belt and its belt and the expansion activities going on in the company it can be expected that the company is all set for a heroic performance in the coming months.
Recs
Strong player in biotech
Recs
Strong cash flow. Good CGQ. Insiders own significant percentage of company stock.
Recs
I am bullish until around $40. From there It will need to be re-evaluated.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 13 of 13